631 related articles for article (PubMed ID: 9003062)
1. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
2. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
3. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides.
Tokuda T; Calero M; Matsubara E; Vidal R; Kumar A; Permanne B; Zlokovic B; Smith JD; Ladu MJ; Rostagno A; Frangione B; Ghiso J
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):359-65. PubMed ID: 10816430
[TBL] [Abstract][Full Text] [Related]
4. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
5. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
Sanan DA; Weisgraber KH; Russell SJ; Mahley RW; Huang D; Saunders A; Schmechel D; Wisniewski T; Frangione B; Roses AD
J Clin Invest; 1994 Aug; 94(2):860-9. PubMed ID: 8040342
[TBL] [Abstract][Full Text] [Related]
7. Association of human, rat, and rabbit apolipoprotein E with beta-amyloid.
LaDu MJ; Lukens JR; Reardon CA; Getz GS
J Neurosci Res; 1997 Jul; 49(1):9-18. PubMed ID: 9211985
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
Butterfield DA; Mattson MP
Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
10. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
Keeney JT; Ibrahimi S; Zhao L
J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
Bentley NM; Ladu MJ; Rajan C; Getz GS; Reardon CA
Biochem J; 2002 Aug; 366(Pt 1):273-9. PubMed ID: 12015813
[TBL] [Abstract][Full Text] [Related]
13. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta.
Martel CL; Mackic JB; Matsubara E; Governale S; Miguel C; Miao W; McComb JG; Frangione B; Ghiso J; Zlokovic BV
J Neurochem; 1997 Nov; 69(5):1995-2004. PubMed ID: 9349544
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding.
Hone E; Martins IJ; Jeoung M; Ji TH; Gandy SE; Martins RN
J Alzheimers Dis; 2005 Aug; 7(4):303-14. PubMed ID: 16131732
[TBL] [Abstract][Full Text] [Related]
15. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
16. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
Stratman NC; Castle CK; Taylor BM; Epps DE; Melchior GW; Carter DB
Chem Phys Lipids; 2005 Oct; 137(1-2):52-61. PubMed ID: 16140289
[TBL] [Abstract][Full Text] [Related]
17. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid.
LaDu MJ; Pederson TM; Frail DE; Reardon CA; Getz GS; Falduto MT
J Biol Chem; 1995 Apr; 270(16):9039-42. PubMed ID: 7721816
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E.
Zhou Z; Smith JD; Greengard P; Gandy S
Mol Med; 1996 Mar; 2(2):175-80. PubMed ID: 8726460
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease.
Evans KC; Berger EP; Cho CG; Weisgraber KH; Lansbury PT
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):763-7. PubMed ID: 7846048
[TBL] [Abstract][Full Text] [Related]
20. ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide.
Drouet B; Fifre A; Pinçon-Raymond M; Vandekerckhove J; Rosseneu M; Guéant JL; Chambaz J; Pillot T
J Neurochem; 2001 Jan; 76(1):117-27. PubMed ID: 11145984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]